Breast Cancer Treatment in India for East African Patients: Kenya, Tanzania & Uganda (2026)

Breast Cancer Looks a Little Different Across East Africa

It helps to start here, because it shapes everything that follows.

In Kenya, breast cancer is the most commonly diagnosed cancer among women, making up roughly 23% of all female cancer cases. In Tanzania, it's the second most common, at around 14–15% of female cancers. And across the region, women are often diagnosed younger than in Europe or the US — which changes real decisions, like whether to discuss fertility preservation before chemotherapy starts.

There's also a harder truth worth saying plainly. Diagnosis often comes later here. Screening access is part of it. So is a genuine shortage of radiotherapy machines across the region. That's not a criticism of local doctors — they're working within real capacity limits. It's simply why so many families end up looking beyond their home country for treatment.

HER2-Positive Breast Cancer — Why It Deserves Its Own Section

If your pathology report mentions "HER2-positive," this section is for you specifically.

HER2-positive breast cancer makes up somewhere between 20% and 25% of all breast cancer cases. It tends to be more aggressive than other types, but here's the important part: the targeted drug trastuzumab has transformed outcomes for HER2-positive patients when it's given consistently, for the full recommended course.

And that word — consistently — is where the real problem sits. A 2022 study from Moi Teaching and Referral Hospital in Eldoret, Kenya, looked at 95 HER2-positive patients. Only 33.6% completed all 18 recommended cycles of trastuzumab. Nearly half received just 4 cycles. That's the number Kenya's national insurance scheme covers. They stopped there — not because their doctor recommended it, but because the funding ran out. Almost a quarter never started the drug at all.

We're not telling you this to alarm you. We're telling you because it's the honest reason full-course HER2 treatment is worth planning for properly. Hoping insurance stretches far enough isn't a plan.

Here's where India fits in. Since 2014, India has approved several biosimilar versions of trastuzumab. Indian manufacturers make them, under strict regulatory approval. Biosimilars aren't a lesser version of the drug. They're clinically equivalent. In Indian hospitals, most HER2-positive patients now get treated with them rather than the original branded product. What changes is the price. It drops substantially compared to the originator drug.

We want to be straight with you here, though. Even at biosimilar pricing, a full trastuzumab course is real money. This isn't a "problem solved" story. It's a "meaningfully more within reach, but still needs a proper plan" story. That's exactly why we give you a full, written estimate before you commit to anything. You should know precisely what a complete course costs. You shouldn't start treatment and just hope you can afford to finish it.

Treatment Options Available in India

Depending on the type and stage, your treatment plan may include:

• Breast-conserving surgery (lumpectomy) — removing the tumour while preserving as much of the breast as possible.
• Mastectomy — full removal of the breast, when it's the safer or more appropriate option.
• Sentinel lymph node biopsy or axillary dissection — checking whether cancer has reached the lymph nodes.
• Chemotherapy — either before surgery to shrink a tumour, or after, to reduce the risk of recurrence.
• Hormone therapy — for hormone-receptor-positive cancers, often continued for several years.
• Targeted therapy (including trastuzumab) — specifically for HER2-positive disease.
• Radiation therapy — commonly after breast-conserving surgery, or after mastectomy in some cases.
• Breast reconstruction — immediate or delayed, depending on your treatment plan and preference.

For younger patients specifically, it's worth raising fertility preservation with your medical team before chemotherapy begins. It's not something every clinic brings up unprompted, so ask directly if it matters to you.

Breast Cancer Treatment Cost in India (2026)

*These are estimates. Your actual cost depends on stage, receptor status, hospital, and whether HER2-targeted therapy or reconstruction is needed. We give you a written, case-specific estimate after reviewing your reports, at no charge.

What Else to Plan For

• Repeat diagnostics on arrival, including confirming your receptor status (ER, PR, HER2), even with recent reports from home.
• The full trastuzumab course, if you're HER2-positive — this is usually costed and planned separately from surgery.
• A longer stay for radiation, which typically runs several weeks of daily sessions.
• Reconstruction as a possible second procedure, if you'd rather stage it after your main treatment is complete.
• Hormone therapy continuation, often needed for five to ten years — this is managed by your home doctor once you're back, but worth planning the handover for.

Your Journey With MediGoCare

1. Send your reports — biopsy results including receptor status (ER, PR, HER2), any imaging, and your treatment history so far. WhatsApp works best: +91 90858 83067.
2. We respond within 48 hours with a written opinion and a cost estimate specific to your diagnosis.
3. Your hospital invitation letter is issued once your treatment plan is confirmed.
4. Visa support, step by step, including the Medical Attendant Visa if a family member is travelling with you.
5. We coordinate your flights and airport pickup.
6. Treatment begins, with a coordinator involved throughout your stay.
7. Discharge, follow-up planning, and a handover summary for your doctor back home.

Getting to India — From Nairobi, Dar es Salaam & Kampala

Direct and one-stop connections exist from all three East African capitals into Delhi, Mumbai, or Chennai, with several major carriers operating the route. If you're travelling from Dar es Salaam specifically, our own branch office is right there — MediGoCare Tanzania operates out of Dar es Salaam, so you can start this conversation with someone in your own city and time zone, before you've booked a single flight.

Best Hospitals for East African Breast Cancer Patients

We work closely with hospitals in the Gurugram cluster — Medanta and Fortis Memorial Research Institute — both of which run full breast oncology units covering surgery, medical oncology, and radiation under one roof. For select complex cases, we also coordinate with Tata Memorial Centre in Mumbai, which handles tens of thousands of oncology patients a year.

We only name hospitals and specialists we've directly confirmed as active partners. If your case needs care outside our current network, we'll say so and help you find the right route regardless.

Why East African Families Work With MediGoCare

We're based in Gurugram, right next to the hospitals we recommend, and we have a branch office in Dar es Salaam for East African families specifically. We won't promise a number we can't back up, and we won't tell you a full HER2 course is simple to afford when it genuinely isn't — we'll give you the real figure, help you plan around it, and stay involved through every step of treatment and the months of follow-up after.

Send Us Your Reports Today

Send your diagnosis and reports through WhatsApp or Email. We'll respond within 48 hours with an honest, written cost estimate. No obligation, no charge for the review.

WhatsApp: +91 90858 83067
Email: info@medigocare.com